- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Smruthi Organics has secured a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its product Amlodipine Besilate. This European quality certification confirms the product meets European Pharmacopoeia standards. It enables Smruthi Organics to supply Amlodipine Besilate to pharmaceutical manufacturers across European markets and other regions that recognize this certification. This achievement significantly strengthens the company's regulatory portfolio and creates new opportunities for market expansion in regulated territories.